Search results

Technologies 1

• CogniXense for Rare Disease Drug Discovery
  Unravel Biosciences has licensed a Wyss drug discovery platform technology to identify and create drugs to treat complex central nervous system disorders, starting with Rett syndrome.

News 32

View all

• Press Release
  
  A CRISPR fingerprint of pathogenic C. auris fungi
  January 14, 2026
• Translation News
  
  Unravel: from tools for studying pathogen tolerance to hope for rare disease patients
  November 20, 2025
• Press Release
  
  Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies
  October 15, 2025

Multimedia 2

• 

  Audio/Podcast
  Xenotransplantation – The Naked Scientists Podcast with George Church
  Amidst the aftermath of COVID-19 waiting lists continue to grow for those in need of an organ transplant, whilst simultaneously in an American surgery a man receives the heart of a pig. Animal donors may be the answer to our shortage of available organs, but the procedure isn’t quite ready to become common place. Take...

• 

  Video/Animation
  CRISPR-Cas: Molecular Recording
  In this video, Wyss Institute and Harvard Medical School researchers George Church and Seth Shipman explain how they engineered a new CRISPR system-based technology that enables the chronological recording of digital information, like that representing still and moving images, in living bacteria. Credit: Wyss Institute at Harvard University